Literature DB >> 24371677

Simultaneous occurrence of well differentiated papillary mesothelioma and endometrioid ovarian cancer: A case report.

Sarah E Gill1, Shawna M Ruple1, C Michael Wolff2, Larry E Puls3.   

Abstract

► We present a case of endometrioid ovarian cancer with concomitant well differentiated papillary mesothelioma of the peritoneum. ► Endometrioid ovarian cancer with concomitant well differentiated papillary mesothelioma is an extremely rare surgical finding of uncertain prognostic significance. ► Treatment with carboplatin and gemcitabine was given with no evidence of disease six months after diagnosis.

Entities:  

Keywords:  Endometrioid; Ovarian cancer; Peritoneal mesothelioma; WDPM

Year:  2013        PMID： 24371677      PMCID： PMC3862221          DOI： 10.1016/j.gynor.2013.01.003

Source DB:  PubMed          Journal:  Gynecol Oncol Case Rep        ISSN： 2211-338X


  6 in total

1.  Malignant transformation of a well-differentiated peritoneal papillary mesothelioma.

Authors:  Rahul Hejmadi; Raji Ganesan; Nahid Gul Kamal
Journal:  Acta Cytol       Date:  2003 May-Jun       Impact factor: 2.319

2.  Update on malignant mesothelioma.

Authors:  Karen Antman; Raffit Hassan; Milton Eisner; Lynn A G Ries; Brenda K Edwards
Journal:  Oncology (Williston Park)       Date:  2005-09       Impact factor: 2.990

Review 3.  Well-differentiated papillary mesothelioma of the peritoneum: a borderline mesothelioma. Report of two cases and review of literature.

Authors:  K F Bürrig; P Pfitzer; W Hort
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1990

Review 4.  Well-differentiated papillary mesothelioma of the peritoneum: a pathological analysis and review of the literature.

Authors:  Anna V Hoekstra; Michael W Riben; Michael Frumovitz; Jinsong Liu; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2005-07       Impact factor: 5.482

5.  Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).

Authors:  D Baratti; S Kusamura; D Nonaka; G D Oliva; B Laterza; M Deraco
Journal:  Ann Surg Oncol       Date:  2007-07-28       Impact factor: 5.344

Review 6.  Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: a review and update.

Authors:  Nelson G Ordóñez
Journal:  Adv Anat Pathol       Date:  2006-01       Impact factor: 3.875
  6 in total
  2 in total

1.  Synchronous presentation of muscle-invasive urothelial carcinoma of bladder and peritoneal malign mesothelioma.

Authors:  Cem Basatac; Fatma Aktepe; Sezer Sağlam; Haluk Akpınar
Journal:  Int Braz J Urol       Date:  2019 Jul-Aug       Impact factor: 1.541

2.  Primary Ovarian Mesothelioma: A Case Series with Electron Microscopy Examination and Review of the Literature.

Authors:  Luigi Vimercati; Domenica Cavone; Maria Celeste Delfino; Biagio Bruni; Luigi De Maria; Antonio Caputi; Stefania Sponselli; Roberta Rossi; Leonardo Resta; Francesco Fortarezza; Federica Pezzuto; Gabriella Serio
Journal:  Cancers (Basel)       Date:  2021-05-10       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.